Located in Rockville, Maryland, GSK's Human Genome Sciences will be Samsung Biologics' first U.S.-based manufacturing site. | ...

Samsung Biologics Co., the biotech arm of Samsung Group, said Monday its U.S. unit has acquired a U.S. biopharmaceutical manufacturing facility from GSK plc for 413.6 billion won (US$280 million) as ...

DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System ...

Samsung Biologics will acquire the Rockville assets for $280m, with closing expected by the end of first quarter of 2026.

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making ...

HENDERSON, NV AND LAS VEGAS, NV / ACCESS Newswire / September 30, 2025 / Precision Biologics Manufacturing, a New Horizon Medical Solutions (NHMS) company, announced a groundbreaking for its ...

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...